Oncology Startup Oncare Raises ₹27 Cr To Expand Clinic Network

Oncology startup Oncare has raised ₹27 Cr (around $3 Mn) in a Series A funding round led by Sky Impact Capital. The round also saw participation from Huddle Ventures, Lotus Herbal Group, SteerX and Tremis Capital.

The startup will use the fresh funds to expand into new metro cities as well as Tier-2 and Tier-3 markets. It also plans to invest in tech that can help it improve clinical operations, care coordination and patient experience.

Founded in 2023 by Amar Sneh and Deepak Kumar, Oncare runs a distributed oncology care model. Instead of building large hospitals, it partners with accredited hospitals and integrates medical, surgical and radiation oncology services under one platform.

Oncare currently operates multiple centres across Delhi NCR and plans to build a wider national network focused on standardised and transparent cancer care.

The investment comes at a time when the Indian oncology market is experiencing dynamic growth, with the market projected to reach ₹43,000 Cr by FY28, growing at around 14% CAGR.

Amid this, investors are doubling down on specialised care models that are addressing hyper niche problems.

The funding comes weeks after Bengaluru-based 4baseCare, which builds AI-driven platform to analyse combined clinical and genomic data, raised ₹90 Cr while healthcare AI startup RISA Labs also raised $11.1 Mn (over ₹100 Cr) in a Series A round co-led by Cencora Ventures and Optum Ventures earlier this year.

The wider healthtech market is expected to grow at 39% CAGR between 2025 and 2030 to cross $37 Bn, according to Inc42’s Annual Indian Startup Trends Report 2025.

Overall, Indian healthtech startups have raised nearly $700 Mn in 2025, as investors continued to back companies working on diagnostics, AI-led treatment support and full-stack care platforms.

The post Oncology Startup Oncare Raises ₹27 Cr To Expand Clinic Network appeared first on Inc42 Media.